# Study of RN0361in Adult Healthy Subjects and Adult Hypertriglyceridemic Subjects

> **NCT06471543** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Ikaria Bioscience Pty Ltd** · enrollment: 108 (estimated)

## Conditions studied

- Hypertriglyceridemia
- Familial Chylomicronemia Syndrome

## Interventions

- **DRUG:** RN0361

## Key facts

- **NCT ID:** NCT06471543
- **Lead sponsor:** Ikaria Bioscience Pty Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-09-30
- **Primary completion:** 2026-06-03
- **Final completion:** 2026-08-26
- **Target enrollment:** 108 (ESTIMATED)
- **Last updated:** 2025-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06471543

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06471543, "Study of RN0361in Adult Healthy Subjects and Adult Hypertriglyceridemic Subjects". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06471543. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*